U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704047) titled 'A Clinical Study of FT1 in Patients With Short Bowel Syndrome' on July 03.
Brief Summary: The goal of this clinical trial is to learn if FT1 is safe and works to treat short bowel syndrome (SBS) in adults. It will also learn about the PK/PD profile of FT1.
Researchers will compare FT1 to a placebo (a look-alike substance that contains no drug) to see if FT1 is safe and effective in patients with SBS.
Participants will
* Receive multiple injections of FT1 or placebo according to weight.
* Visit the clinic for assessment.
Study Start Date: Aug. 30
Study Type: INTERVENTIONAL
Condition:
Short Bowel Syndrome
SBS
Intervention:
D...